Soratrium 30 Tablets

Soratrium 30 Tablets

Therapeutic Class:
Manufacturer:
Get Quote

ScyFIX micro-current neuromodulation (MCN) has been successful in treating other degenerative eye diseases like Macular Degeneration (ARMD), and is expected to become the standard of care for these blindness-causing diseases. ARMD is a major cause for the deterioration of eyesight in older age groups, affecting an estimated 50+ million people world-wide. It is estimated that 5% of the entire world population will develop a form of ARMD.

The ScyFIX 700 MCN device is approved for use in Europe (CE MARK). The ScyFIX MCN solution is expected to become the therapy of choice for other low-vision blindness causing diseases like Diabetic Retinopathy, Stargardt’s, Open Angle Glaucoma, CMV-Retinitis, as well as Presbyopia. More than 2000 people have been successfully treated with MCN Therapy. ScyFIX intends to become the world leader in the distribution of effective, non-invasive therapies for the treatment of chronic eye disorders.

NA
NA
Pack Size: 1 UNIT
Uses: Treatment for Retinitis Pigmentosa and Dry Age-Related Macular Degeneration (“ARMD”)
Table Header
Salt Composition
Strength
Pack Size
1 UNIT
Uses
Treatment for Retinitis Pigmentosa and Dry Age-Related Macular Degeneration (“ARMD”)
SKU df23a7991bc5 Category
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Soratrium 30 Tablets which is also known as and Manufactured by Intas Optima. It is available in strength of Soratrium 30 Tablets is supplied for Pharmacies / Drug Stores / Hospitals / Ship Chandlers Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:
×